Development of a potent class of small molecule inhibitors of the MDM2-p53 protein-protein interaction

被引:1
|
作者
Fazal, Lynsey [1 ]
Ahn, Maria [1 ]
Bevan, Luke [1 ]
Buck, Ildiko [1 ]
Castro, Juan [1 ]
Chessari, Gianni [1 ]
Cons, Ben [1 ]
Hearn, Keisha [1 ]
Howard, Steven [1 ]
Johnson, Chris [1 ]
Reeks, Judith [1 ]
Tamanini, Emiliano [1 ]
Thompson, Neil [1 ]
Walton, Hugh [1 ]
Williams, Pamela [1 ]
Bawn, Ruth H. [2 ]
Blackburn, Tim J. [2 ]
Cano, Celine [2 ]
Cully, Sarah J. [2 ]
Golding, Bernard [2 ]
Griffin, Roger [2 ]
Haggerty, Karen [2 ]
Hardcastle, Ian [2 ]
Newell, Herbie [2 ]
Noble, Martin [2 ]
Thomas, Huw [2 ]
Willmore, Elaine [2 ]
Zhao, Yan [2 ]
Wedge, Steve [2 ]
机构
[1] Astex Therapeut, Cambridge, England
[2] Nothern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
10.1158/1538-7445.AM2018-1652
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1652
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Identification of equal affinity MDMX/MDM2-p53 interaction small molecule inhibitors
    Reed, Damon
    Mills, Nicholas
    Guy, R. Kip
    Dyer, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3404S - 3404S
  • [32] Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity
    Brandao, Pedro
    Loureiro, Joana B.
    Carvalho, Sylvie
    Hamadou, Meriem Hadjer
    Cravo, Sara
    Moreira, Joana
    Pereira, Daniela
    Palmeira, Andreia
    Pinto, Madalena
    Saraiva, Lucilia
    Cidade, Honorina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 156 : 711 - 721
  • [33] Protein-protein recognition: a computational mutagenesis study of the MDM2-P53 complex
    Moreira, Irina S.
    Fernandes, Pedro A.
    Ramos, Maria J.
    THEORETICAL CHEMISTRY ACCOUNTS, 2008, 120 (4-6) : 533 - 542
  • [34] Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction
    Zhuang, Chunlin
    Miao, Zhenyuan
    Zhu, Lingjian
    Zhang, Yongqiang
    Guo, Zizhao
    Yao, Jianzhong
    Dong, Guoqiang
    Wang, Shengzheng
    Liu, Yang
    Chen, Hai
    Sheng, Chunquan
    Zhang, Wannian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5654 - 5661
  • [35] Small-molecule MDM2-p53 inhibitors: recent advances
    Zhang, Bian
    Golding, Bernard T.
    Hardcastle, Ian R.
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (05) : 631 - 645
  • [36] Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors
    Bazanov, Daniil R.
    Pervushin, Nikolay, V
    Savin, Egor, V
    Tsymliakov, Michael D.
    Maksutova, Anita, I
    Sosonyuk, Sergey E.
    Kopeina, Gelina S.
    Lozinskaya, Natalia A.
    MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (12) : 2216 - 2227
  • [37] Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein-protein interaction
    Gureev, Maxim
    Novikova, Daria
    Grigoreva, Tatyana
    Vorona, Svetlana
    Garabadzhiu, Alexander
    Tribulovich, Vyacheslav
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2020, 34 (01) : 55 - 70
  • [38] Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors
    Daniil R. Bazanov
    Nikolay V. Pervushin
    Egor V. Savin
    Michael D. Tsymliakov
    Anita I. Maksutova
    Sergey E. Sosonyuk
    Gelina S. Kopeina
    Natalia A. Lozinskaya
    Medicinal Chemistry Research, 2021, 30 : 2216 - 2227
  • [39] Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions
    Blackburn, Tim J.
    Ahmed, Shafiq
    Coxon, Christopher R.
    Liu, Junfeng
    Lu, Xiaohong
    Golding, Bernard T.
    Griffin, Roger J.
    Hutton, Claire
    Newell, David R.
    Ojo, Stephen
    Watson, Anna F.
    Zaytzev, Andrey
    Zhao, Yan
    Lunec, John
    Hardcastle, Ian R.
    MEDCHEMCOMM, 2013, 4 (09) : 1297 - 1304
  • [40] Design and preclinical pharmacological evaluation of a cleavable succinate ester solubilizing group for isoindolinone MDM2-p53 protein-protein interaction inhibitors
    Zhao, Yan
    Thomas, Huw
    Liu, Junfeng
    Blackburn, Timothy J.
    Cully, Sarah
    Watson, Anna F.
    Hardcastle, Ian R.
    Golding, Bernard T.
    Griffin, Roger J.
    Lunec, John
    Newell, David R.
    CANCER RESEARCH, 2012, 72